Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja D de Gruijl

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Journal for Immunotherapy of Cancer|May 13, 2026
Local immunotherapy for the treatment of cancer: scientific advances and clinical potentialHoward L Kaufman, Tanja D de Gruijl
Advances in Cancer Research|October 2, 2012
Chapter six--Adenovirus-based immunotherapy of cancer: promises to keepTanja D de Gruijl, Rieneke van de Ven
Experimental Dermatology|September 14, 2022
From simplicity to complexity in current melanoma modelsElisabetta Michielon, Tanja D de Gruijl, Susan Gibbs
European Journal of Immunology|May 1, 2010
Epidermis-to-dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5Krista Ouwehand, Rik J Scheper, Tanja D de Gruijl, et al.
Expert Opinion on Biological Therapy|May 12, 2015
Arming oncolytic viruses to leverage antitumor immunityTanja D de Gruijl, Axel B Janssen, Victor W van Beusechem
Toxicology and Applied Pharmacology|June 2, 2015
MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposureIlona J Kosten, Sander W Spiekstra, Tanja D de Gruijl, et al.
ALTEX|May 20, 2016
MUTZ-3 Langerhans cell maturation and CXCL12 independent migration in reconstructed human gingivaIlona J Kosten, Sander W Spiekstra, Tanja D de Gruijl, et al.
Cell Reports. Medicine|October 14, 2025
Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulationGeorgia Clayton, Elisa C Toffoli, Tanja D de Gruijl, et al.
Frontiers in Immunology|December 11, 2013
Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and SuppressionRieneke van de Ven, Jelle J Lindenberg, Dinja Oosterhoff, et al.
Current Opinion in Oncology|September 10, 2015
Recent developments and future challenges in immune checkpoint inhibitory cancer treatmentBas D Koster, Tanja D de Gruijl, Alfons J M van den Eertwegh
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|May 13, 2026
Local immunotherapy for the treatment of cancer: scientific advances and clinical potentialHoward L Kaufman, Tanja D de Gruijl
Advances in Cancer Research|October 2, 2012
Chapter six--Adenovirus-based immunotherapy of cancer: promises to keepTanja D de Gruijl, Rieneke van de Ven
Experimental Dermatology|September 14, 2022
From simplicity to complexity in current melanoma modelsElisabetta Michielon, Tanja D de Gruijl, Susan Gibbs
European Journal of Immunology|May 1, 2010
Epidermis-to-dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5Krista Ouwehand, Rik J Scheper, Tanja D de Gruijl, et al.
Expert Opinion on Biological Therapy|May 12, 2015
Arming oncolytic viruses to leverage antitumor immunityTanja D de Gruijl, Axel B Janssen, Victor W van Beusechem
Toxicology and Applied Pharmacology|June 2, 2015
MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposureIlona J Kosten, Sander W Spiekstra, Tanja D de Gruijl, et al.
ALTEX|May 20, 2016
MUTZ-3 Langerhans cell maturation and CXCL12 independent migration in reconstructed human gingivaIlona J Kosten, Sander W Spiekstra, Tanja D de Gruijl, et al.
Cell Reports. Medicine|October 14, 2025
Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulationGeorgia Clayton, Elisa C Toffoli, Tanja D de Gruijl, et al.
Frontiers in Immunology|December 11, 2013
Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and SuppressionRieneke van de Ven, Jelle J Lindenberg, Dinja Oosterhoff, et al.
Current Opinion in Oncology|September 10, 2015
Recent developments and future challenges in immune checkpoint inhibitory cancer treatmentBas D Koster, Tanja D de Gruijl, Alfons J M van den Eertwegh
Pageof 27